AI Smart Glasses Secure £1 Million Prize for Revolutionary Dementia Support
An innovative AI software designed for integration into smart glasses has been awarded a prestigious £1 million prize for its groundbreaking technology aimed at assisting individuals living with dementia. The system, known as CrossSense, is embedded within chunky black-rimmed frames equipped with a camera, microphone, and speakers, providing wearers with a chatty virtual assistant named Wispy.
How CrossSense Enhances Daily Life for Dementia Patients
The CrossSense technology guides users through everyday activities by delivering verbal cues and displaying floating text directly in their field of vision. Wispy not only offers prompts and feedback during tasks but also engages in light conversation, asks questions, and aids in reminiscence therapy, fostering a more interactive and supportive experience.
This software has triumphed in the Longitude prize on dementia, an award initiative designed and delivered by Challenge Works with support from Nesta. The prize, funded by Alzheimer's Society and Innovate UK, seeks to spur technological advancements that help people with dementia maintain their independence longer, addressing a growing global health concern. By 2050, approximately 150 million people worldwide are projected to be living with dementia.
Market Launch and Pilot Program Details
Szczepan Orlins, CEO of CrossSense Ltd, announced that the prize money will accelerate the product's journey to market. A smartphone version of the AI assistant is slated for release by the end of this year, with the CrossSense-enabled smart glasses expected to become available in early 2027. Orlins emphasized that while CrossSense Ltd develops the AI software, the team collaborates with various hardware companies to produce frames that can accommodate prescription lenses and are compatible with hearing aids.
"With the prize, we will be running a pilot with smart glasses in the last quarter of 2026 for four weeks in people's homes, which would give us enough data to know that this is ready," Orlins stated. He added that user-specific information, such as care needs, can be input via an accompanying app, allowing Wispy to utilize machine learning to adapt to individual requirements and changes in condition.
Pricing, Accessibility, and Initial Research Findings
The CrossSense technology is projected to cost around £50 per month via subscription, while the smart glasses themselves may retail for up to £1,000, though prices could decrease over time. Initially marketed directly to consumers, the long-term goal is to make these glasses available through the NHS, enhancing accessibility for those in need.
Professor Julia Simner of the University of Sussex, who served as the science lead for the project, conducted tests with 23 pairs of individuals living with dementia and their caregivers. Although the study has not yet undergone peer review, preliminary results are promising: participants with dementia correctly identified only 46% of household items without the glasses, but this figure soared to 82% when using the technology.
"Crucially, the benefit lasted even after the glasses were removed," Simner noted, revealing that an hour after removal, the accuracy rate remained at 78%.
Expert Insights and Ethical Considerations
Dr. Foyzul Rahman, a cognitive decline expert at Loughborough University not involved in the project, highlighted that CrossSense's breakthrough lies in providing real-time prompts and feedback during tasks, rather than mere one-off reminders. However, he cautioned that larger, more rigorously controlled studies or randomized trials are necessary to assess whether such devices yield meaningful benefits in daily life.
Rahman also pointed out ethical considerations regarding consent, given the technology's data collection capabilities, and practical challenges such as the current one-hour battery life, which necessitates a portable power bank. He questioned whether users would consistently adopt assistive technologies despite these hurdles.
User Testimonials and Future Prospects
For Carole Greig, a 70-year-old diagnosed with Alzheimer's nearly three years ago who has tested the glasses, the technology represents a beacon of hope. "For people with the condition like mine who've got cognitive impairment, it's just an amazing thing," she expressed. "How fantastic that we can be given some more independence, that we're going to be able to cope on our own and not be a burden. And not only that, it's not just not being a burden, it's enjoying your life."
As the global dementia population continues to rise, innovations like CrossSense underscore the potential of AI and wearable technology to transform care and improve quality of life, offering a glimpse into a future where technology and compassion converge to support vulnerable communities.
